Department of Radiation Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, Guangdong, China.
Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Diseases, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, Guangdong, China.
Sci Rep. 2023 Mar 24;13(1):4832. doi: 10.1038/s41598-023-31845-9.
Cataract, the leading cause of blindness worldwide, is caused by crystallin protein aggregation within the protected lens environment. Phase separation has been implicated as an important mechanism of protein aggregation diseases, such as neurodegeneration. Similarly, cataract has been proposed to be a protein condensation disease in the last century. However, whether crystallin proteins aggregate via a phase separation mechanism and which crystallin protein initiates the aggregation remain unclear. Here, we showed that all types of crystallin-GFP proteins remain soluble under physiological conditions, including protein concentrations, ion strength, and crowding environments. However, in age or disease-induced aberrant conditions, α-crystallin-GFP, including αA- and αB-crystallin-GFP, but not other crystallin-GFP proteins, undergo phase separation in vivo and in vitro. We found that aging-related changes, including higher crystallin concentrations, increased Na, and decreased K concentrations, induced the aggregation of α-crystallin-GFP. Furthermore, HO, glucose, and sorbitol, the well-known risk factors for cataract, significantly enhanced the aggregation of αB-crystallin-GFP. Taken together, our results revealed that α-crystallin-GFP forms aggregates via a phase transition process, which may play roles in cataract disease. Opposite to the previously reported function of enhancing the solubility of other crystallin, α-crystallin may be the major aggregated crystallin in the lens of cataract patients.
白内障是全球致盲的主要原因,它是由晶状体蛋白在受保护的晶状体环境中聚集引起的。相分离已被认为是蛋白质聚集疾病(如神经退行性疾病)的重要机制。同样,在上个世纪,白内障被提出是一种蛋白质凝聚疾病。然而,晶状体蛋白是否通过相分离机制聚集,以及哪种晶状体蛋白首先发生聚集仍不清楚。在这里,我们表明所有类型的晶状蛋白-GFP 蛋白在生理条件下(包括蛋白浓度、离子强度和拥挤环境)都保持可溶性。然而,在年龄或疾病引起的异常条件下,α-晶状体蛋白-GFP,包括αA-和αB-晶状体蛋白-GFP,但不是其他晶状蛋白-GFP 蛋白,在体内和体外发生相分离。我们发现,与衰老相关的变化,包括更高的晶状体浓度、增加的 Na 和减少的 K 浓度,诱导α-晶状体蛋白-GFP 的聚集。此外,HO、葡萄糖和山梨醇,白内障的已知风险因素,显著增强了αB-晶状体蛋白-GFP 的聚集。总之,我们的结果表明,α-晶状体蛋白-GFP 通过相转变过程形成聚集体,这可能在白内障疾病中起作用。与先前报道的增强其他晶状蛋白可溶性的功能相反,α-晶状体蛋白可能是白内障患者晶状体中主要的聚集晶状蛋白。